| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $5.93B | $6.06B | $4.32B | $2.71B | $1.83B |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | $2.83B | $2.23B |
| R&D | – | – | – | – | – |
| SG&A | $238.54M | $268.91M | $285.76M | $218.94M | $455.82M |
| Operating Income | -$463.24M | -$292.13M | -$232.13M | -$120.43M | -$393.95M |
| Interest Expense | – | – | $6.66M | $4.53M | $6.15M |
| Tax Expense | $1.25M | $1.45M | $791.00K | $1.64M | $886.00K |
| Net Income | -$391.35M | -$260.15M | -$262.60M | -$106.55M | -$406.49M |
| EPS (basic) | – | – | – | – | – |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | $413.97M | $410.97M | $408.92M | $408.15M | $372.93M |